Computer interface technology promises a ‘smart pacemaker’ to help sufferers of the motor disease
Authorities are rushing to contain latest outbreak fuelled by a more dangerous type of the virus
Jab makers fall behind Moderna in post-pandemic market with disappointing results
Leading producer says it needs orders to ramp up supply with outbreaks surging in central and east Africa
The Food and Drug Administration’s rejection of MDMA-assisted therapy is a missed opportunity
Global health body calls for action to tackle ‘very worrying’ outbreak of highly transmissible virus
Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study
A surge in infections will boost companies’ shares but this sector’s volatility makes them a poor long-term bet
Pharma groups and patients say guidance prioritising mass trials threaten drug development
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse
Nice’s backing for Casgevy comes after UK became first country to give drug regulatory approval
Pharma companies are moving up the supply chain to secure radioactive materials for a new form of drugs
That many of the cancers are gastrointestinal offers clues and could point to microplastics
Swiss drugmaker examines options for Flatiron Health after acquisition has disappointed
Maker of Wegovy and Ozempic has 45,000 patients in clinical trials as it seeks to stave off threats from Eli Lilly and Roche
Patients in Manchester will take part in first study using ‘wonder material’ that was discovered in the city
For years, the process for developing and testing new drugs has focused disproportionately on male bodies — to the detriment of female patients
Reducing 14 ‘modifiable’ risks can prevent or delay cognitive disorder, report says
The illness causes more deaths than strokes but a new time-saving technology may be able to help
Nice blames cost for not recommending Enhertu, which has helped patients in clinical trials live longer
Extreme shortages of actinium are holding up the promising field of radiopharmaceuticals
Eisai and Biogen face uphill battle to win EU approval for Leqembi after committee’s ruling
Chan Siun-kuen left rural China in the slipstream of the revolution for a rapidly urbanising Hong Kong. His herb garden restores a connection to forgotten traditions and the healing power of plants
GSK’s Shingrix is latest drug to show potential for targeting previously untreatable brain disorders
Amber alert triggered as blood stocks fall to ‘unprecedentedly low levels’
